04/29/2024 3:16 PM | Intellia Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024 3:10 PM | Dube Michael P (Reporting) Intellia Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/15/2024 3:21 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 8:26 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2024 6:04 AM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024 4:22 PM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024 4:17 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
02/22/2024 6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2024 3:00 PM | ARK Investment Management LLC (Filed by) Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024 10:21 AM | Intellia Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/10/2024 3:15 PM | Intellia Therapeutics (Issuer) Sepp-Lorenzino Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:35 PM | BlackRock Inc. (Filed by) Intellia Therapeutics (Subject)
| Form SC 13G/A | |
01/05/2024 3:44 PM | Clark Eliana (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:45 PM | BASTA JAMES (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:46 PM | Hicks Derek (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:49 PM | Goddard Glenn (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:50 PM | Intellia Therapeutics (Issuer) Sepp-Lorenzino Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:50 PM | Intellia Therapeutics (Issuer) Lebwohl David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:51 PM | Intellia Therapeutics (Issuer) LEONARD JOHN M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 4:28 PM | Goddard Glenn (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:30 PM | Intellia Therapeutics (Issuer) LEONARD JOHN M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:34 PM | Intellia Therapeutics (Issuer) Lebwohl David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:35 PM | Intellia Therapeutics (Issuer) Sepp-Lorenzino Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 7:09 PM | Crowley John F (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/24/2023 8:30 AM | Intellia Therapeutics (Filer)
| Form S-3ASR | |
11/09/2023 6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:42 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 6:11 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 6:30 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 6:19 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 3:13 PM | Intellia Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023 6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/02/2023 4:19 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2023 3:45 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023 4:21 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:22 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/06/2023 2:34 PM | Clark Eliana (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 4:52 PM | Clark Eliana (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 6:39 PM | Clark Eliana (Reporting) Intellia Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Tech GIANT’s Plans to Revolutionize Crypto… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Claim your free seat by clicking here now. |
06/16/2023 3:24 PM | Bhanji Muna (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:26 PM | Cohen Fred E (Reporting) Intellia Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:13 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2023 6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2023 3:52 PM | Intellia Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |